Published • loading... • Updated
Alnylam gets EU approval for Amvuttra in heart disorder treatment
Summary by Seeking Alpha
5 Articles
5 Articles
Alnylam receives the approval of the European Commission for AMVUTTRA® (vutrisiran) for the treatment of transtiretin cardiac amyloidosis (ATTR)
·Italy
Read Full ArticleReposted by
Anti-Aging, Acupuncture and Health News
Mavacamten Showing Real-World Success in Treating oHCM
Two years after being recommended for NHS use, mavacamten is improving outcomes for patients with symptomatic obstructive hypertrophic cardiomyopathy. Medscape News UK
·United States
Read Full ArticleCoverage Details
Total News Sources5
Leaning Left0Leaning Right2Center0Last UpdatedBias Distribution100% Right
Bias Distribution
- 100% of the sources lean Right
100% Right
R 100%
Factuality
To view factuality data please Upgrade to Premium

